Potential roles of gut microbiota and microbial metabolites in chronic inflammatory pain and the mechanisms of therapy drugs
- PMID: 35924009
- PMCID: PMC9340317
- DOI: 10.1177/20406223221091177
Potential roles of gut microbiota and microbial metabolites in chronic inflammatory pain and the mechanisms of therapy drugs
Abstract
Observational findings achieved that gut microbes mediate human metabolic health and disease risk. The types of intestinal microorganisms depend on the intake of food and drugs and are also related to their metabolic level and genetic factors. Recent studies have shown that chronic inflammatory pain is closely related to intestinal microbial homeostasis. Compared with the normal intestinal flora, the composition of intestinal flora in patients with chronic inflammatory pain had significant changes in Actinomycetes, Firmicutes, Bacteroidetes, etc. At the same time, short-chain fatty acids and amino acids, the metabolites of intestinal microorganisms, can regulate neural signal molecules and signaling pathways, thus affecting the development trend of chronic inflammatory pain. Glucocorticoids and non-steroidal anti-inflammatory drugs in the treatment of chronic inflammatory pain, the main mechanism is to affect the secretion of inflammatory factors and the abundance of intestinal bacteria. This article reviews the relationship between intestinal microorganisms and their metabolites on chronic inflammatory pain and the possible mechanism.
Keywords: arthritis; chronic inflammatory pain; glucocorticoids; intestinal microflora; nonsteroidal anti-inflammatory drugs.
© The Author(s), 2022.
Conflict of interest statement
Competing interests: The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Figures
References
-
- Treede RD, Rief W, Barke A, et al.. Chronic pain as a symptom of a disease: the IASP Classification of Chronic Pain for the International Classification of Diseases (ICD-11). Pain 2019; 160: 19–27. - PubMed
-
- Magistro G, Wagenlehner FM, Grabe M, et al.. Contemporary management of chronic prostatitis/chronic pelvic pain syndrome. Eur Urol 2016; 69: 286–297. - PubMed
-
- Appiya Santharam M, Khan FU, Naveed M, et al.. Interventions to chronic prostatitis/Chronic pelvic pain syndrome treatment. Where are we standing and what’s next? Eur J Pharmacol 2019; 857: 172429. - PubMed
-
- van der Woude D, van der Helm-van Mil AHM. Update on the epidemiology, risk factors, and disease outcomes of rheumatoid arthritis. Best Pract Res Clin Rheumatol 2018; 32: 174–187. - PubMed
-
- Vitkov L, Hannig M, Minnich B, et al.. Periodontal sources of citrullinated antigens and TLR agonists related to RA. Autoimmunity 2018; 51: 304–309. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
